Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
Reset Pharmaceuticals has raised $11.1M in total funding. The most recent round was Series A. The last funding was announced in February 2022.
Reset Pharmaceuticals's investors include PsyMed Ventures, Negev Capital, Ayuh Ventures.
Reset Pharmaceuticals is headquartered in Great Neck, United States.
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.
Reset Pharmaceuticals is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reset Pharmaceuticals — Funding & Investors." VCBacked, February 16, 2022, https://www.vcbacked.co/company/reset-pharmaceuticals. Accessed September 29, 2026.
VCBacked. (2022). Reset Pharmaceuticals — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/reset-pharmaceuticals
{{cite web |title=Reset Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/reset-pharmaceuticals |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated